Several pharmaceutical companies are making strides in the weight-loss drug market with the introduction of generic versions of GLP-1 receptor agonists. Eli Lilly's weight-loss drug is impacting competitors like ResMed and Inspire Medical. Teva has launched a generic version of Novo Nordisk's diabetes drug, liraglutide, with a higher dose catering to obesity. The market is seeing increased competition and potential pricing changes as more generics enter the scene.
"America’s insatiable demand for weight-loss medications is minting vast fortunes—and not just for the makers of GLP-1 drugs such as Ozempic." - @david_wainer https://t.co/2iTAzuGJE5 $LLY $HIMS
Generic Liraglutide Is Here – Will It Make Any Difference? - ConscienHealth https://t.co/cPNSgUCPTY greed and inertia in this market are good descriptions
Heard on the Street: Once Eli Lilly and Novo Nordisk increase the supply of weight-loss medications, companies such as Hims & Hers may find it trickier to sell compounded versions of the drugs https://t.co/X4T9xXWBjo
Generic Liraglutide Is Here – Will It Make Any Difference? - ConscienHealth https://t.co/9ZDjqHBTdd
Generic liraglutide is here. Will it lead to a moderation in pricing of diabetes and #ObesityMedicines? Maybe, but not right away. Here's why. https://t.co/6iDAsF57Dg
Generic #Liraglutide Is Here – Will It Make Any Difference? - @ConscienHealth https://t.co/970AOEUnLy
Which is the better investable theme: AI or weight loss drugs? “They are both enormous markets, but there are at least 30 molecules in development for obesity,” says @Karen_Firestone. “Right now, Nvidia doesn’t have any type of competition.” $NVDA $LLY $NVO https://t.co/BCwNufleA9
From Sci-Fi Dream to Market Maze: Eli Lilly's Weight-Loss Medication Faces Hurdles $LLY $NVO $VRTX $ABBV $JNJ $MRK $AMGN #stocks #investing #valueinvesting #Momentum #HealthCare #US #Buffett #largecap https://t.co/tCxR24Anb0
@Teva launches generic version of @novonordisk’s #diabetes GLP-1ra drug, liraglutide (#Victoza) | The higher dose of 3mg daily is the obesity version but perhaps the cost of this will help more people in need! https://t.co/moFwssJE7W
GLP1 Generics: It Has Begun Generic Liraglutide (Victoza) Becomes First Generic GLP-1 Receptor Agonist https://t.co/K354yv8qnH https://t.co/DgSEIuxu9C
Eli Lilly's Weight-Loss Drug Takes Down ResMed, Inspire Medical — Again https://t.co/MvGNHBQZuU